Xiangxue Deng is the first recipient of the UTMB-Novartis Alliance for Pandemic Preparedness (UNAPP) Drug Discovery Scholar Award.
Welcome to the Sealy Institute for Drug Discovery
The Institute for Drug Discovery capitalizes UTMB’s world-class research in infectious disease, neuroscience, and other disciplines for therapeutics development. Through academic and industrial partnerships, we integrate the best interdisciplinary teams to discover small molecules and biologics for treatment of diseases.
Our drug discovery for pandemic preparedness is empowered by the Galveston National Laboratory, the largest biosafety-level-4 facility in the world on an academic campus, and well-established pathogen models at UTMB.
We seek collaborations with academia, industry, government, and philanthropy to develop medicines to improve and extend human lives.
Sanja Sever, PhD
Vice President, Drug Discovery
Director, Sealy Institute for Drug Discovery
John Sealy Distinguished Chair in Innovations in Molecular Biology
New Funding for Antiviral Research
The Sealy Institute for Drug Discovery (SIDD) is soliciting preproposals for feasibility and pilot projects that will result in preliminary data and subsequent funding for drug discovery research.